Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,663 followers.

RT @FrontOncology: New research: Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impair…

20 Jan 2024

Reply Repost Favourite

New research: Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report: Background Gray zone lymphoma (GZL) is a rare lymphoma subtype characterized by features intermediate… https://t.c

20 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.